oncology management

Research in Review

Adverse Event Linked to Everolimus Does Not Negatively Impact Survival

05/13/2016

JCP Editors

Incidence of a common adverse event should not be considered a hindrance to the administration of everolimus for patients with cancer, according to a recent study. Everolimus is an oral mammalian target of rapamycin...

...

05/13/2016

Journal of Clinical Pathways

Research in Review

Surgery Offers Survival Benefit to Older Patients With Lung Cancer

05/12/2016

JCP Editors

Patients 65 years and older who receive surgery for lung cancer are living longer, claims a recent study. According to national records, lung cancer most commonly occurs in older adults, with the median age at...

...

05/12/2016

Journal of Clinical Pathways

Research in Review

Chemoradiotherapy Does Not Improve Survival for Patients With Pancreatic Cancer

05/11/2016

JCP Editors

Adding radiation to chemotherapy regimens may not improve overall survival compared with chemotherapy alone in patients with locally advanced pancreatic cancer, according to results from a clinical trial. The trial,...

Adding...

05/11/2016

Journal of Clinical Pathways

Counterpoint

Keeping Cures on the Shelf

05/06/2016

George Dahlman ;

Regulatory action has been taken to address the problem of drug shortages for pediatric cancer patients. However, there is still more work to be done. During 2010 and 2011, the news headlines were filled with...

...

05/06/2016

Journal of Clinical Pathways

Strict Adherence to Ibrutinib Therapy Improves PFS for Chronic Lymphocytic Leukemia

05/05/2016

JCP Editors

Ibrutinib may improve progression-free survival (PFS) for patients with chronic lymphocytic leukemia (CLL) if the full dose is taken on schedule, according to results extracted from clinical trial data and presented...

...

05/05/2016

Journal of Clinical Pathways

Same Survival and Toxicity With APBI and WBI for Breast Cancer

05/04/2016

JCP Editors

Accelerated partial breast irradiation (APBI) leads to the same rates of survival and toxicity as whole breast irradiation (WBI) while also producing significantly better cosmetic results, according to phase 3 trial...

...

05/04/2016

Journal of Clinical Pathways

SBRT for Patients With NSCLC Linked to Higher Rates of Non-Cancer Death

05/04/2016

JCP Editors

Using stereotactic body radiation therapy (SBRT) to treat patients with non-small cell lung cancer (NSCLC) may slightly increase the risk of dying from a cause other than cancer, according to research presented at...

Using...

05/04/2016

Journal of Clinical Pathways

Breast Conserving Therapy Likely to Result in Recurrence

05/03/2016

JCP Editors

Women younger than 45 years who opt for breast conserving therapy (BCT) over mastectomy may have a higher risk of developing a local recurrence over a 20-year period, according to research presented at European...

Women...

05/03/2016

Journal of Clinical Pathways

Radiation Therapy Better for Testicular Cancer Than Chemotherapy

05/02/2016

JCP Editors

Radiation therapy may be superior to chemotherapy for patients with stage 2a-b testicular cancer, according to results presented at European Society for Therapeutic Radiology and Oncology (ESTRO) 35 (April 29-May 3,...

...

05/02/2016

Journal of Clinical Pathways

Algorithm Improves Adverse Event Response for Patients Receiving Immunotherapies

05/02/2016

JCP Editors

A standard algorithm created by a nurse-led collaborative team helped clinicians better assess and manage adverse events in patients receiving immunotherapy for cancer, according to an oral presentation at the...

A...

05/02/2016

Journal of Clinical Pathways